WENA anewmeds.com Net earnings per share growth this year

Official company branding of Anew Medical Inc. (WENA)

Anew Medical, Inc. (WENA) is developing a biopharmaceutical environment for the treatment of neurodegeneration via the Klotho protein and patent protection. Current annual EPS growth illustrates the financial dynamics, where 0.00 serves as the current parameter value. The company minimizes environmental impact during laboratory operations. Following the reverse merger, the business relies on the internal development of gene therapy and university licenses, excluding new asset acquisition deals.

Earnings growth in current year: Anew Medical Inc. (WENA) for 06/25/2024 - 09/17/2024

Financial and market metric breakdowns for Anew Medical Inc. (WENA)

- stock price and consensus target price:
Fundamental valuation:Anew Medical, Inc.
Mass-produced product of Anew Medical

This indicator measures the dynamics of net earnings per share adjusted for debt service costs, neutralizing the lags of standard reporting during periods of tight Fed monetary policy. Analyzing the annual EPS growth trend allows an investor to assess the real efficiency of business capitalization and the risk of cash flow gaps. For Anew Medical, Inc. (WENA), such a metric reflects financial stability while implementing costly developments in the field of gene therapy for neurodegenerative diseases.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Earnings growth in current year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth in current year|Expected net earnings per share growth this year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth in current year|NeuroBo Pharmaceuticals Inc - Earnings per share increase in current year|SAGE (Sage Therapeutics Inc.) - Earnings growth in current year|Earnings per share growth this year SNPX (Neurotrope)|Earnings per share growth in current year Trevena Inc. (TRVN)|VIGL - Earnings per share growth rate in current year|Earnings per share growth in current year Cerevel Therapeutics CERE